Intermede Investment Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$79.8M Sell
270,331
-14,628
-5% -$4.34M 3.7% 10
2025
Q4
$77.8M Buy
+284,959
New +$77.4M 3.2% 12
2025
Q1
Sell
-556,034
Closed -$129M 34
2024
Q4
$129M Sell
556,034
-153,697
-22% -$35.3M 3.45% 11
2024
Q3
$157M Sell
709,731
-13,639
-2% -$2.82M 3.27% 11
2024
Q2
$142M Sell
723,370
-48,006
-6% -$9.92M 3.01% 15
2024
Q1
$166M Sell
771,376
-246,777
-24% -$51.8M 3.39% 12
2023
Q4
$214M Sell
1,018,153
-49,926
-5% -$10.7M 4.87% 6
2023
Q3
$214M Sell
1,068,079
-42,367
-4% -$8.42M 5.48% 5
2023
Q2
$206M Sell
1,110,446
-1,156
-0.1% -$214K 4.8% 7
2023
Q1
$213M Sell
1,111,602
-110,855
-9% -$20M 5.22% 6
2022
Q4
$206M Buy
1,222,457
+104,111
+9% +$18.1M 5.74% 4
2022
Q3
$198M Buy
1,118,346
+82,142
+8% +$16.2M 5.55% 4
2022
Q2
$212M Buy
1,036,204
+29,987
+3% +$6.36M 5.88% 4
2022
Q1
$239M Buy
1,006,217
+66,208
+7% +$15.5M 5.6% 4
2021
Q4
$215M Sell
940,009
-32,874
-3% -$7.23M 4.42% 8
2021
Q3
$188M Sell
972,883
-9,774
-1% -$1.98M 4.33% 6
2021
Q2
$209M Buy
982,657
+46,903
+5% +$9.9M 4.75% 6
2021
Q1
$191M Buy
935,754
+155,129
+20% +$30.6M 4.88% 5
2020
Q4
$142M Buy
780,625
+243,181
+45% +$41.4M 4.11% 13
2020
Q3
$89.9M Buy
537,444
+20,580
+4% +$3.47M 3.76% 16
2020
Q2
$84M Buy
516,864
+12,418
+2% +$2.23M 4.11% 15
2020
Q1
$87.2M Buy
504,446
+20,235
+4% +$4.03M 5.14% 7
2019
Q4
$97.2M Buy
484,211
+7,797
+2% +$1.6M 4.92% 8
2019
Q3
$101M Sell
476,414
-5,584
-1% -$1.17M 5.59% 2
2019
Q2
$93.6M Sell
481,998
-7,306
-1% -$1.35M 5.54% 2
2019
Q1
$80.5M Buy
489,304
+58,754
+14% +$10.4M 5.01% 6
2018
Q4
$81M Buy
430,550
+21,506
+5% +$3.97M 6.47% 1
2018
Q3
$69.6M Buy
409,044
+16,286
+4% +$2.74M 5.22% 5
2018
Q2
$64.4M Sell
392,758
-13,136
-3% -$2.15M 5.09% 4
2018
Q1
$65.6M Sell
405,894
-23,297
-5% -$3.71M 5.64% 3
2017
Q4
$62.7M Buy
429,191
+19,814
+5% +$2.82M 5.33% 5
2017
Q3
$55.5M Buy
409,377
+1,009
+0.2% +$127K 5.08% 7
2017
Q2
$51.1M Buy
408,368
+74,393
+22% +$8.9M 4.95% 8
2017
Q1
$39.7M Sell
333,975
-24,043
-7% -$2.89M 4.15% 9
2016
Q4
$41.3M Sell
358,018
-9,460
-3% -$1.05M 4.84% 5
2016
Q3
$38.4M Buy
367,478
+4,529
+1% +$473K 4.25% 9
2016
Q2
$35.4M Buy
362,949
+7,286
+2% +$689K 4.1% 11
2016
Q1
$34.2M Buy
355,663
+103,892
+41% +$9.45M 4.12% 11
2015
Q4
$22.8M Buy
+251,771
New +$23.7M 3.86% 13

Other funds holding CME

Intermede Investment Partners's CME Position: Q1 2026 in Review

Intermede Investment Partners reduced its CME Group (CME) stake by 5.1% in Q1 2026, selling an estimated $4.34M and leaving 270,331 shares worth $79.8M. The position accounts for 3.7% of the portfolio, ranked #10.

Intermede Investment Partners first reported a position in CME in Q4 2015 and has held it in 39 quarters since. The position peaked at $239M in Q1 2022. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Intermede Investment Partners held 270,331 shares of CME Group worth $79.8M as of Q1 2026.
  • Intermede Investment Partners sold 14,628 CME Group shares in Q1 2026, an estimated $4.34M.
  • CME Group made up 3.7% of Intermede Investment Partners's portfolio in Q1 2026, its #10 holding.
  • Intermede Investment Partners first reported a position in CME Group in Q4 2015 and has held it in 39 quarters since.
  • Intermede Investment Partners's CME Group position peaked at $239M in Q1 2022.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Intermede Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.